Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in most parts of the world. Although there is no first-line drug approved for the treatment of NAFLD, polyene phosphatidylcholine (PPC) is used by clinicians to treat NAFLD patients. This study aimed to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiayuan, Zang, Xiaoling, Lv, Jinxiao, Zhang, Yicong, Lv, Zhihua, Yu, Mingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862520/
https://www.ncbi.nlm.nih.gov/pubmed/36675016
http://dx.doi.org/10.3390/ijms24021502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862520/
https://www.ncbi.nlm.nih.gov/pubmed/36675016
http://dx.doi.org/10.3390/ijms24021502

Ejemplares similares